VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,858,937 | -34.4% | 1,587,717 | 0.0% | 0.02% | -41.7% |
| Q2 2023 | $10,463,055 | -2.9% | 1,587,717 | 0.0% | 0.04% | -5.3% |
| Q1 2023 | $10,780,598 | +91782.7% | 1,587,717 | 0.0% | 0.04% | -9.5% |
| Q4 2022 | $11,733 | -99.9% | 1,587,717 | -0.1% | 0.04% | -30.0% |
| Q3 2022 | $15,708,000 | -43.0% | 1,589,860 | -37.1% | 0.06% | -41.2% |
| Q2 2022 | $27,539,000 | +83.0% | 2,526,480 | +89.9% | 0.10% | +142.9% |
| Q1 2022 | $15,050,000 | +112.1% | 1,330,712 | +194.3% | 0.04% | +100.0% |
| Q4 2021 | $7,095,000 | +374.9% | 452,220 | +418.9% | 0.02% | +320.0% |
| Q3 2021 | $1,494,000 | -3.4% | 87,145 | +21.2% | 0.01% | 0.0% |
| Q2 2021 | $1,546,000 | -73.4% | 71,875 | -81.5% | 0.01% | -79.2% |
| Q1 2021 | $5,822,000 | -11.6% | 387,605 | -22.7% | 0.02% | -17.2% |
| Q4 2020 | $6,585,000 | +47.8% | 501,168 | +8.7% | 0.03% | +16.0% |
| Q3 2020 | $4,455,000 | -16.7% | 461,184 | -1.4% | 0.02% | -26.5% |
| Q2 2020 | $5,351,000 | – | 467,728 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
| Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
| Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
| Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
| Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
| Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
| EMC Capital Management | 16,185 | $176,000 | 0.15% |